Market revenue in 2023 | USD 155.7 million |
Market revenue in 2030 | USD 324.2 million |
Growth rate | 11% (CAGR from 2023 to 2030) |
Largest segment | Ballon sinus dilation devices |
Fastest growing segment | Functional Endoscopic Sinus Surgery (FESS) Instruments Set |
Historical data | 2016 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Ballon Sinus Dilation Devices, Endoscopes, Sinus Stents/Implants, Functional Endoscopic Sinus Surgery (FESS) Instruments Set |
Key market players worldwide | Medtronic PLC, Smith & Nephew PLC, Stryker Corp, Intersect ENT, Olympus Corp, Johnson & Johnson, TE Connectivity Ltd, SinuSys Corp., InnAccel |
Ballon sinus dilation devices was the largest segment with a revenue share of 48.62% in 2023. Horizon Databook has segmented the Japan sinus dilation device market based on ballon sinus dilation devices, endoscopes, sinus stents/implants, functional endoscopic sinus surgery (fess) instruments set covering the revenue growth of each sub-segment from 2016 to 2030.
Japan sinus dilation devices market held 25% shares in 2020 owing to rising R&D efforts by key players operating in the market to deliver novel products. For instance, in March 2017, according to a report published by Olympus Corporation, the company introduced a new surgical endoscope with infra-red imaging capability and named the product, VISERA ELITE II surgical endoscope system.
Furthermore, an increase in adoption of minimally invasive surgical procedures is projected to further fuel the market growth. According to a report published by Intersect ENT, Inc. in 2017, approximately 450,000 FESS procedures were performed in Japan.
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account